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ScienceDirectCandida albicans is a commensal coloniser of most people and
a pathogen of the immunocompromised or patients in which
barriers that prevent dissemination have been disrupted. Both
the commensal and pathogenic states involve regulation and
adaptation to the host microenvironment. The pathogenic
potential can be downregulated to sustain commensalism or
upregulated to damage host tissue and avoid and subvert
immune surveillance. In either case it seems as though the cell
biology of this fungus has evolved to enable the establishment
of different types of relationships with the human host. Here we
summarise latest advances in the analysis of mechanisms that
enable C. albicans to occupy different body sites whilst
avoiding being eliminated by the sentinel activities of the
human immune system.
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Introduction
Candida albicans is the commonest serious fungal patho-
gen of humans, variously reported as causing between
250 000 and 400 000 deaths per annum worldwide as well
as extensive morbidity of around 100 million episodes
of recurrent vaginitis [1,2]. This fungus is a classical
opportunistic pathogen residing harmlessly as a commen-
sal in approximately 50% of individuals [1], kept in check
by our immune system and a protective bacterial micro-
biome of the gut and other mucosal surfaces [2–4]. In
this review we survey latest advances in the cell biology of
C. albicans that underpins its ecology as an organismwww.sciencedirect.com exploring the interface between commensalism and path-
ogenesis.
Life as a successful saprophyte
C. albicans is a largely asexual fungus, but never-the-less it
is morphologically and physiologically a highly variable
and adaptable fungus. It is pleomorphic — being able to
grow either as a budding yeast, or as a pseudomycelium of
elongated and conjoined yeast cells or as true hyphae
formed of generate parallel-sided tip-growing filaments
[5]. It also exhibits a non-sexual form of variation called
phenotypic switching that can generate stable cell and
colony variants with distinct properties [6]. C. albicans can
thrive in different host niches (gut, vagina, oral mucosa,
skin) without causing disease. This observation suggests
it is adapted for commensalism. GI tract colonization
seems to involve predominantly carriage of the yeast form
of the fungus, and low level systemic dissemination in the
gut can occur even in yeast-locked mutants [7]. However,
a mouse model of stable gastrointestinal candidiasis dem-
onstrated that passage of C. albicans through the mamma-
lian gut leads to the transition to a modified yeast cell,
‘GUT phenotype’ (gastrointestinally induced transition),
that expresses a specialised transcriptome in the digestive
tract to promote assimilation of common nutrients in the
bowel. These GUT cells are morphologically altered and
suppress the propensity for tissue invasion and the ex-
pression of certain virulence traits [8]. Therefore, the
commensal state does not solely depend on host immune
status and is also supported by organism-specific adapta-
tions mediated by transcriptional changes in the host-
associated commensal state [9].
Changes in the availability of nutrients in the gut due to
dietary intake, can further impact the abundance of
Candida [10], and changes in diet or gut fungal microbiota
may lead to dysbiosis and inflammatory pathologies such
as Crohn’s disease [11,12]. Although Candida colonisation
may promote gut inflammation under certain circum-
stances, chitin, a component of the Candida cell wall,
has anti-inflammatory properties and has the potential to
ameliorate inflammatory bowel disease (IBD) if exposed
in the gut [13]. Also host mutations in, for example, fungal
immune recognition receptors such as dectin-1, the im-
mune signalling molecule CARD9 and the inflammatory
cytokine IL-22 result in susceptibility to colitis and other
forms of IBD [14,15]. In a mouse model, tryptophan
metabolites from some specific members of the gutCurrent Opinion in Microbiology 2016, 34:111–118
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colonisation by controlling secretion of IL-22 in stomach
[16]. Probiotic supplements are also known to suppress
the fungal mycobiome [17]. Therefore the commensal
status of Candida is also related to the host microbiome as
a whole and the immune status of the host.
Collectively, these observations suggest that gut com-
mensalism of Candida is related to both intrinsic factors
(fungal gene regulation, cell morphology, adaptation,
fungal burden) and extrinsic factors (competitive micro-
biome, diet, host immune status). We know less about the
factors affecting colonisation at other body sites although
it is likely that a similar complex array of factors sustain
the commensal state in these host niches.
Life as a successful pathogen
During the course of infection C. albicans colonizes vari-
ous host niches, with differences, for example, in nutrient
availability, pH, hypoxia and CO2 levels [18,19]. One of
the key features establishing C. albicans as a successful
pathogen is its adaptability to successfully thrive in these
different conditions [18]. Host microenvironments have
heterogeneous carbon sources and, as it traverses through
different host niches, C. albicans can adapt to use alterna-
tive carbon sources simultaneously, for its survival and
virulence [18–20]. This adaptation has resulted from the
absence of catabolite inactivation due to the rewiring of
ubiquitination sites in metabolic enzymes [21,22]. The
metabolic flexibility of Candida also contributes to the
alterations in the cellular proteome and secretome [23],
and its ability to undergo yeast to hyphal transition, white-
opaque switching [24], biofilm formation, as well as its
adhesion characteristics [23,25], and the capacity for cell
wall remodelling [19,20,23,26]. Changes in cell wall poly-
saccharide composition [19,20,25], modifies the patho-
gen’s sensitivity to environmental stress and antifungals
[18,20,23,25], but also affect its immunogenicity by alter-
ing the expression and presentation of critical pathogen-
associated molecular patterns (PAMPs), thus making
C. albicans a moving target for the recognition by the
host immune system [19,20,21,25–27].
The human host withholds the availability of micronu-
trients, like Fe, Zn, Cu and Mn, from the pathogen in a
process termed ‘nutritional immunity’ [28]. These micro-
nutrients are essential for many vital cellular functions
in the pathogen [28]. Countering this, C. albicans has
evolved mechanisms to overcome host nutritional immu-
nity by expressing micronutrient transporters (e.g. Rbt5/
Als3 for Fe; Zrt1/Zrt2/soluble Pra1 for Zn) [28], or redun-
dant enzymes that use alternative micronutrients as cofac-
tors [29].
C. albicans expresses a number of proteases, phospholi-
pases, lipases and esterases (reviewed in [30]), which
function in the degradation of host connective tissues,Current Opinion in Microbiology 2016, 34:111–118 cleavage of host immune defence proteins, and thus aid
nutrition acquisition, invasion and evasion of the patho-
gen from host immune defence [30,31]. These hydrolases
belong to multigene families, and each family member
has a different substrate specificity, pH optimum, and
expression profile [30]. Of these the secreted aspartyl
proteases (Saps) have been shown to have important
multiple roles. Regulation of the expression of this 10-
membered gene family is regulated principally by host
carbon and nitrogen sources and by pH [32]. Sap2 inacti-
vates Factor-H and the complement receptors CR3 and
CR4 on macrophages, thus mediating the escape of
C. albicans from recognition by the host’s innate immune
system [33]. In mice, Anti-Sap2 antibodies or the protease
inhibitor pepstatin A can reduce Sap2-mediated vaginal
inflammation caused by C. albicans [34]. Sap2 and Sap6
have also been shown to induce inflammatory cytokine
production by the host through the type I IFN, and
caspase-11 induction as well as NLRP3 inflammasome
activation [35,36]. Following their uptake by the host
epithelial cells, hypha-specific Saps4-6 cause lysosomal
permeabilization and triggering of caspase-1 dependent
apoptosis [37].
Recently, an entirely novel secretory host cell lysing
agent from C. albicans, called ‘candidalysin’, has been
described. The lytic activity is encoded by one of eight
Kexp-processed peptides from the ECE1 gene product.
The Ece1-III62–93 peptide alone can induce damage to
epithelial membranes and the activation of a danger
response in host epithelial immunity [38].
These evolutionary adaptive traits enable C. albicans to
survive in various host niches, counter host immune
defences and help C. albicans in establishing itself as a
successful pathogen (Figure 1).
Controlling interactions with human epithelia
and endothelia
Two complementary mechanisms are involved in
C. albicans host cell invasion through epithelial cells
(EC) (Figure 3). Fungal-induced endocytosis contributes
to the early stages of invasion, a process of host produced
pseudopods surrounding the fungus to pull it into the host
cell. By contrast, active penetration occurs at later time
points when hyphae invade between or through ECs [39].
Although the mechanisms involved depend on invasion
stage, fungal morphology and epithelial lineage, both are
triggered by hypha-associated factors [40]. Notably, sys-
temic dissemination, which is not dependent on morpho-
logical transition, occurs from the GI tract and trans-
epithelial transport of the yeast form might be mediated
by indirect mechanisms, such as by lumen sampling
dendritic cells or M cell transcytosis [7].
Both the oral and vaginal epithelial immune response
differs to the presence of hyphae and yeast cells ofwww.sciencedirect.com
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Candida virulence factors. Virulence is a polygenic trait in C. albicans involving biochemical, physiological, genetic and morphogenetic
characteristics.C. albicans so that only large numbers of hyphae activate a
host biphasic MKP1 and c-Fos dependent response lead-
ing to inflammatory cytokine formation [41]. This may
allow the epithelium to control the pattern of immune
activation so it is responsive mainly to fungal invasion
rather than colonisation. Low level colonisation, may
progress to the establishment of a mature surface biofilm,
but as yet it is not clear how the establishment of a
Candida biofilm may affect mucosal infection and immu-
nity [42]. However, it would seem likely that mature
biofilms would present challenges for the cellular im-
mune system to clear such dense biomass mats.
Multiple stimuli including EC contact and body temper-
ature trigger hyphal morphogenesis. C. albicans produces
early virulence factors that are downstream of the processwww.sciencedirect.com of invasion itself [43]. These include the expression of the
GPI-linked cell surface proteins Hwp1 and the invasin
Als3 or Ssa1, a member of HSP70 family [40]. Hwp1,
under control of the transcription factor Bcr1 regulating
biofilm formation, acts as a substrate for epithelial trans-
glutaminases and is required for mucosal pathogenicity
[39]. Als3 and Ssa1 mediate binding to host epithelial
surface receptors which enable the fungus to attach to and
invade host cells. Host ligands include E-cadherin on
ECs, N-cadherin on endothelial cells and EGF receptor
on oral ECs [40]. During induced endocytosis this inter-
action stimulates host cytoplasmic proteins to form cla-
thrin-coated vesicles surrounding the fungus for an actin
dependent internalization. E-cadherin interaction is how-
ever not necessary for endocytosis of C. albicans into
enterocytes [44]. Recently it has been shown thatCurrent Opinion in Microbiology 2016, 34:111–118
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Interaction of C. albicans with macrophages showing the stages at which the fungus can deploy immune avoidance mechanisms. The
macrophage uses chemotaxis to target the fungal cell, then fungus recognition and engulfment take place via interaction of fungal PAMPs and a
series of immune cell PRRs that includes phagocytic receptors. The Candida cell is delivered to the phagosomal vesicle which undergoes fusion
with lysosomes to create the mature acidic phagolysosome that can kill the fungal cargo using oxidative and nitrosative elements. However, C.
albicans has the capacity to interfere with the phagolysomal maturation programme, increase its alkalinity, generate protective antioxidants and
induce its own non-lytic expulsion. In addition, hypha formation and induced pyroptosis can cause the lysis of the phagocyte.C. albicans Als adhesins are also involved in adhesion to
C. glabrata during oropharyngeal candidiasis (OPC) en-
abling C. glabrata to colonize and persist in the oral
mucosa and cavity [45].
During active penetration, C. albicans secretes hydrolytic
enzymes (described in previous section) that affect epi-
thelial cell–cell junctions and facilitate degradation of cell
membrane components along with other ligands that
facilitate fungal adhesion [39]. Cell surface localized
superoxide dismutase detoxifies reactive oxygen species
(ROS) produced when tissue is damaged and is also
expressed on the surface of invading hyphae [46,47].
Many other internal and cell wall-associated proteins also
indirectly affect C. albicans adhesion and virulence, for
example, proteins involved in protein trafficking and
required for a functional vesicle transport system or
proteins involved in hyphal formation, growth or cellular
orientation. Others have a crucial role in cell wall assem-
bly and integrity, or they modify other adhesins required
for epithelial binding [39].
Interactions with phagocytes
Almost every component of the cell wall of Candida has
been shown to have a role in the interactions between host
and pathogen. Immune recognition of Candida is mediated
by PAMP engagement with host pattern recognitionCurrent Opinion in Microbiology 2016, 34:111–118 receptors (PRRs). These recognition events are dominat-
ed by binding of fungal cell wall carbohydrates, although
the cell wall proteins also contribute to shaping the
immune response [3,4]. Recently it has become clear that
the innate immune response, which is of principle impor-
tance in conferring immunity, can be trained by prior
exposure to Candida. As a consequence memory of prior
innate immune interactions is epigenetically imprinted in
the host and results in enhanced immune responses in
subsequent encounters with the fungus. The paradigm of
immunological memory was thought previously to be
encoded entirely by the adaptive immune system but is
clearly also a feature of innate immunity [48,49].
It is also increasingly evident that the immune response
to Candida is influenced by yeast-hypha morphogenesis
[50]. Hyphae specifically activate the NLRP3 inflamma-
some resulting in IL-1b secretion [51] and yeast and
hyphae are differentially bound to, taken up and pro-
cessed by phagocytes [3]. In addition, other morphologi-
cal transitions, such as the switching from the white to the
opaque form of this organism results in differential phago-
cytosis and the suppression of the production of phago-
cyte chemoattractants [52,53].
Resisting phagocytes
Following internalisation of the fungal target cell, matura-
tion of the phagosome into phagolysosome is fundamentalwww.sciencedirect.com
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C. albicans interaction with host cells. [a] I invasion into oral
epithelium with hyphae that have penetrated the host cells marked (*).
[b] Phagocytosis by mouse peritoneal macrophages with extracellular
parts of C. albicans stained with an anti-Candida Ab in green and
counterstained with CFW in blue. The macrophages are stained red
with phalloidin (F-actin) to visualize phagocytic uptake. [c] Human
peripheral blood mononuclear cells aggregated around yeast cells and
hyphae of C. albicans.to fungal killing. The importance of phagolysosomes in
promoting fungal killing is associated with the presence of
cationic peptides, hydrolytic enzymes, ROS and reactive
nitrogen species (RNS); which are generated in a vacuole
with an acidic pH [3,54]. Hence, in order to survive thewww.sciencedirect.com harmful environment of the phagolysosome, C. albicans has
developed strategies to allow its survival by the manipula-
tion and escape from phagocytic cells (Figures 2 and 3)
[54,59].
C. albicans promotes neutralization of the phagolysosome,
in a process that requires the Stp2 transcription factor
induction of the Ato5-mediated ammonia exporter
[55,56]. The subsequent neutralization of the acidic en-
vironment of the phagolysosome allows C. albicans hyphal
morphogenesis to occur hence facilitating its escape from
macrophages [55,56]. In addition, the PKC-Mkc1-Rlm1
cell wall salvage pathway is also activated resulting in
reinforcing chitin being made in the cell wall [57,58].
When inside the phagosome Candida also induces a
battery of protective enzymes and proteins including
catalase, superoxide dismutase, thioredoxin, flavo-hae-
moglobin, glutathione recycling enzymes that degrade
or scavenge RNS and ROS [47,60]. Consequently, dele-
tion of key regulators of oxidative and nitrosative stress
response results in increased sensitivity to phagocyte
killing [47,60]. Multiple individual imposed toxic stresses
have been shown to exert synergistic effects on the ability
to kill Candida. These studies illustrate the importance of
the Hog1 MAPK and the Cap1 transcription factor in the
regulation of combinatorial stress responses [60,61].
Candida cells share a property with Cryptococcus and other
fungi to be able to induce their own non-lytic expulsion
from macrophages (sometimes called vomocytosis), with-
out any damage to the phagocyte [62]. By contrast,
numerous studies have reported the ability of elongating
hyphae to pierce the membrane of a macrophage result-
ing in their release [3]. However, there is no clear relation
between yeast-hypha morphogenesis and macrophage
lysis.
It is now clear that Candida hyphal cells can also induce
pyroptosis in the host phagocyte — a form of pro-
grammed cell death that is dependent on caspase-1
activation of the NLRP3 inflammasome [63–66]. Howev-
er, although hyphae promote pyroptosis, pyroptosis is not
always coincident with hypha formation. For example, a
vps35 mutant formed hyphae normally but failed to
induce macrophage lysis whilst, alg1 and alg11 mutants
are hypha-deficient yet induced macrophage lysis via
pyroptosis [67].
Therefore the cell biology of Candida is well adapted to
resist the killing potential of phagocytes thereby limiting
the effectiveness of some elements of the adaptive im-
mune system.
Conclusion
C. albicans has numerous cell biology attributes that
enable it to exist commensally in the human body. TheseCurrent Opinion in Microbiology 2016, 34:111–118
116 Fungi and parasitic diseasesfeatures presumably account for the fact that most
healthy humans are colonised by this organism. However,
its metabolic, morphogenetic and immunomodulatory
properties means that it is also a pernicious and common
pathogen in almost any setting in which immune vigour is
compromised or the physical integrity of the host surface
is disrupted. As a commensal organism Candida has likely
acquired traits and properties that also enable it to flourish
as a pathogen [68]. Commensal cells also have to avoid
being eliminated by overcoming immune surveillance
mechanisms that act to protect the mucosa. This organism
can therefore ‘have its cake and eat it’ by withholding its
full pathogenic potential under conditions of host im-
mune fitness or aggressively invading the weakened host.
In both situations this fungus shows remarkable flexibility
and adaptability in its capacity for survival in the human
body.
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